Balancing Growth Prospects and Regulatory Challenges: A Hold Rating on PTC Therapeutics
Joseph Schwartz, an analyst from Leerink Partners, reiterated the Hold rating on PTC Therapeutics (PTCT – Research Report). The ...
PTC Inc. Reports Strong Growth in 2024
PTC Inc. ( (PTC) ) has released its Q4 earnings. Here is a breakdown of the information PTC Inc. presented to its investors. PTC Inc. is a ...
SFGate6d
PTC Inc.: Fiscal Q4 Earnings Snapshot
BOSTON (AP) — BOSTON (AP) — PTC Inc. (PTC) on Wednesday reported fiscal fourth-quarter earnings of $126.5 million. The Boston-based company said it had net income of $1.04 per share.
PTC Inc.: Fiscal Q4 Earnings Snapshot
BOSTON (AP) — BOSTON (AP) — PTC Inc. (PTC) on Wednesday reported fiscal fourth-quarter earnings of $126.5 million. The Boston-based company said it had net income of $1.04 per share. Earnings, ...